Company page

Icure Pharmaceutical Incorporation

Icure Pharmaceutical Incorporation, trading under the ticker 175250, operates in the Korean market with a market capitalization of approximately 53.8 million USD. The company focuses on developing innovative pharmaceutical solutions. Investors can find relevant information and updates about Icure Pharmaceutical on its public company page.